Validation of the innovative clinical endpoint capture methods in the pragmatic multi-center randomized trial "Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long- term Effectiveness (ADAPTABLE)"

在务实的多中心随机试验“阿司匹林剂量：以患者为中心的试验评估益处和长期有效性（ADAPTABLE）”中验证创新的临床终点捕获方法

• 批准号: 376317
• 负责人: Marquis-Gravel Guillaume
• 金额: $ 8.74万
• 依托单位: Duke Clinical Research Institute (NC)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-11-01 至 2019-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=376317&lang=en
• 关键词: Aspirin; Atherosclerotic Cardiovascular Diseases; Cardiology; Patient-Oriented Outcomes; Pragmatic Trial; Randomized Controlled Trial; Secondary Prevention

Clinical trials of good quality are necessary to assess the efficacy and safety of new medical treatments. However, long-term follow-up of patients treated with novel therapies is often complex and expensive, hindering the implementation of high-scale res

高质量的临床试验对于评估新药物治疗的有效性和安全性是必要的。然而，对接受新疗法治疗的患者进行长期随访通常是复杂和昂贵的，阻碍了高规模研究的实施。